Showing results (431-440 of 538) with videos related to

Sort By:
Pageof 54
Annals of the Rheumatic Diseases|February 25, 2011
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|November 2, 2019
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapiesManuel Ramos-Casals, Pilar Brito-Zerón, Stefano Bombardieri, et al.
Plos One|May 30, 2013
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohortJacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, et al.
Annals of the Rheumatic Diseases|April 25, 2020
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitorsMarie Kostine, Axel Finckh, Clifton O Bingham, et al.
RMD Open|September 2, 2021
Lymphoma complicating rheumatoid arthritis: results from a French case-control studyJoanna Kedra, Raphaele Seror, Philippe Dieudé, et al.
Cytokine|May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infectionVincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
Oncoimmunology|December 8, 2018
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancerAlexandre Ivagnès, Meriem Messaoudene, Gautier Stoll, et al.
The Lancet. Rheumatology|August 1, 2025
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trialJacques Morel, Emmanuelle Dernis, Christian Roux, et al.
Annals of the Rheumatic Diseases|March 3, 2016
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task forceCindy Strehl, Johannes W J Bijlsma, Maarten de Wit, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 21, 2022
Variability of Primary Sjögren's Syndrome Is Driven by Interferon-α and Interferon-α Blood Levels Are Associated With the Class II HLA-DQ LocusDiana Trutschel, Pierre Bost, Xavier Mariette, et al.
Pageof 54